Aurora Cannabis (ACB) Research & Development (2017 - 2026)

Aurora Cannabis (ACB) has reported Research & Development for 10 consecutive years, with $680272.7 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 13.7% year-over-year to $680272.7 in Q2 2026; TTM through Jun 2026 was $3.0 million, a 18.43% increase from a year earlier, with the FY2026 full-year figure at $2.9 million, up 10.06% from the prior year.
• Research & Development was $680272.7 for Q2 2026 at Aurora Cannabis, down from $718996.8 in the prior quarter.
• Over five years, Research & Development peaked at $3.0 million in Q4 2022 and troughed at $547079.4 in Q1 2025.
• A 5-year average of $1.1 million and a median of $710188.6 in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 135.15% in 2022 and tumbled 81.05% in 2023, its largest moves.
• Over 5 years, Research & Development stood at $3.0 million in 2022, then plunged by 81.05% to $574406.8 in 2023, then increased by 15.78% to $665023.9 in 2024, then jumped by 40.5% to $934363.4 in 2025, then decreased by 27.19% to $680272.7 in 2026.
• The last three Research & Development figures came in at $680272.7 (Q2 2026), $718996.8 (Q1 2026), and $934363.4 (Q4 2025), per Business Quant data.